ArticleClinical and experimental immunology2013

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.

P Cipriani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.